gp100 (630-638)

gp100 (630-638) is a synthetic peptide fragment derived from the human gp100 glycoprotein, specifically encompassing amino acid residues 630 to 638. As a well-characterized epitope, this peptide is of significant interest in immunological and cancer research, particularly in studies focused on antigen presentation and T cell recognition. Its defined sequence and structural features make it a valuable tool for dissecting the molecular mechanisms underlying immune targeting of melanoma-associated antigens. Researchers utilize this peptide to explore the intricacies of peptide-MHC interactions, T cell specificity, and immune modulation, thereby advancing understanding in tumor immunology and peptide-based assay development.

Antigen Presentation Studies: The gp100 (630-638) peptide serves as a critical reagent for investigating antigen processing and presentation by major histocompatibility complex (MHC) molecules, particularly in the context of HLA-A2. By loading this epitope onto antigen-presenting cells, researchers can model and quantify the efficiency of peptide-MHC complex formation, facilitating the evaluation of T cell activation thresholds and elucidating the parameters that govern immune recognition of tumor-associated antigens.

T Cell Functional Assays: In functional immunology studies, this peptide is widely employed to stimulate and expand antigen-specific cytotoxic T lymphocytes (CTLs) from peripheral blood mononuclear cells or established T cell lines. Its application enables the assessment of T cell receptor (TCR) specificity, effector function, and cytokine response upon recognition of the gp100-derived epitope. Such assays are instrumental in profiling T cell responses, mapping immunodominant regions, and validating the immunogenicity of candidate epitopes.

Peptide-MHC Tetramer Production: The defined sequence of gp100 (630-638) allows its use in the generation of peptide-MHC tetramers, which are essential tools for the direct detection and quantification of antigen-specific T cells by flow cytometry. By incorporating this peptide into tetrameric complexes, researchers can precisely identify and characterize T cell populations that recognize the gp100 epitope, enabling detailed analysis of T cell repertoire diversity, frequency, and functional phenotype in both basic and translational research settings.

Peptide-Based Vaccine Research: The gp100 (630-638) fragment is frequently utilized in preclinical studies aiming to design and optimize peptide-based immunogens targeting melanoma antigens. Its inclusion in vaccine formulations or immunization protocols supports the evaluation of peptide immunogenicity, adjuvant selection, and delivery strategies, as well as the measurement of induced antigen-specific immune responses. Such research contributes to the rational development of next-generation immunotherapeutic approaches.

Epitope Mapping and Immune Monitoring: The availability of this synthetic peptide facilitates high-resolution epitope mapping studies, allowing researchers to delineate the minimal recognition motifs required for T cell activation. Additionally, it plays a pivotal role in immune monitoring protocols, where it is used to track the presence, frequency, and functional status of gp100-specific T cells in samples from experimental models or ex vivo human studies. These applications are fundamental for understanding immune dynamics in tumor biology and for evaluating the efficacy of immunomodulatory interventions.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines